Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

FEV1 (% predicted): mean change from baseline · children over 12 and adults with CFRD

Summary of findings: repaglinide showed no clear difference in FEV1 % predicted change from baseline compared with insulin (moderate certainty).

1 finding from 1 review

Drug treatments for managing cystic fibrosis‐related diabetes 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 112 participants
Moderate

FEV1 (% predicted): mean change from baseline · adults with CFRD

Summary of findings: repaglinide showed no clear difference in FEV1 % predicted; change from baseline compared with placebo (low certainty).

1 finding from 1 review

Drug treatments for managing cystic fibrosis‐related diabetes 2020 · Cochrane Headline outcomes only
MD 1.7
1 study · 38 participants
Low